Postmenopausal Oral 17β-Estradiol Continuously Combined with Dydrogesterone Reduces Fasting Serum Homocysteine Levels
- 1 May 1998
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 69 (5) , 876-882
- https://doi.org/10.1016/s0015-0282(98)00041-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal womenFertility and Sterility, 1997
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Plasma homocysteine and menopausal status**European Journal of Clinical Investigation, 1995
- Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifenInternational Journal of Cancer, 1995
- Homocyst(e)ine and arterial occlusive diseasesJournal of Internal Medicine, 1994
- Hormone replacement therapy may reduce high serum homocysteine in postmenopausal womenEuropean Journal of Clinical Investigation, 1994
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991
- Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular diseaseEuropean Journal of Clinical Investigation, 1988
- Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years.Journal of Clinical Investigation, 1983